HCA Healthcare, Inc.
HCA Healthcare, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 940 | 1,040 | 997 | 939 | 1,060 | 1,933 | 2,888 | 831 | 1,284 | 935 | 891 | 862 | |||||
Accounts Receivable Net Current | 11,324 | 10,867 | 10,428 | 10,459 | 11,088 | 10,751 | 9,915 | 10,239 | 10,044 | 9,958 | 9,182 | 8,713 | |||||
Inventory Net | 1,681 | 1,652 | 1,734 | 1,792 | 1,794 | 1,738 | 1,776 | 1,800 | 1,903 | 2,021 | 2,030 | 2,050 | |||||
Other Assets Current | 2,107 | 2,224 | 2,126 | 2,373 | 2,316 | 1,992 | 2,083 | 2,303 | 2,051 | 2,013 | 2,191 | 2,263 | |||||
Assets Current | 16,052 | 15,783 | 15,285 | 15,563 | 16,258 | 16,414 | 16,662 | 15,173 | 15,282 | 14,927 | 14,294 | 13,888 | |||||
Property And Equipments | |||||||||||||||||
Land | - | 3,415 | - | - | - | 3,295 | - | - | - | 3,120 | - | - | |||||
Buildings And Improvements Gross | - | 23,726 | - | - | - | 22,691 | - | - | - | 21,560 | - | - | |||||
Machinery And Equipment Gross | - | 36,989 | - | - | - | 34,670 | - | - | - | 31,998 | - | - | |||||
Construction In Progress Gross | - | 2,145 | - | - | - | 1,858 | - | - | - | 1,870 | - | - | |||||
Property Plant And Equipment Gross | 67,365 | 66,275 | 65,489 | 64,388 | 63,680 | 62,514 | 61,750 | 60,625 | 59,440 | 58,548 | 57,772 | 56,667 | |||||
Accumulated Depreciation Depletion And Amortizatio… | -35,893 | -35,134 | -34,921 | -34,265 | -33,942 | -33,100 | -32,703 | -31,986 | -31,344 | -30,833 | -30,655 | -30,023 | |||||
Property Plant And Equipment Net | 31,472 | 31,141 | 30,568 | 30,123 | 29,738 | 29,414 | 29,047 | 28,639 | 28,096 | 27,715 | 27,117 | 26,644 | |||||
Available For Sale Securities Debt Securities Nonc… | 387 | 485 | 573 | 531 | 550 | 569 | 553 | 483 | 471 | 477 | 382 | 384 | |||||
Equity Method Investments | 615 | 633 | 654 | 654 | 657 | 662 | 705 | 702 | 736 | 756 | 739 | 731 | |||||
Intangible Assets Net Including Goodwill | 10,504 | 10,293 | 10,275 | 10,273 | 10,237 | 10,093 | 9,982 | 9,963 | 9,967 | 9,945 | 9,778 | 9,641 | |||||
Operating Lease Right Of Use Asset | 2,094 | 2,130 | 2,115 | 2,156 | 2,132 | 2,131 | 2,201 | 2,179 | 2,211 | 2,207 | 2,079 | 2,110 | |||||
Other Assets Noncurrent | 326 | 255 | 277 | 236 | 226 | 230 | 309 | 240 | 199 | 184 | 200 | 196 | |||||
Assets | 61,450 | 60,720 | 59,747 | 59,536 | 59,798 | 59,513 | 59,459 | 57,379 | 56,962 | 56,211 | 54,589 | 53,594 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 4,806 | 4,659 | 4,552 | 4,250 | 4,488 | 4,276 | 4,235 | 4,029 | 4,735 | 4,233 | 4,139 | 3,823 | |||||
Accrued Salaries Current | 2,022 | 2,525 | 2,294 | 2,072 | 1,857 | 2,304 | 2,164 | 1,993 | 1,759 | 2,127 | 1,912 | 1,776 | |||||
Other Accrued Liabilities Current | 3,898 | 4,277 | 4,940 | 4,513 | 3,767 | 3,899 | 3,819 | 3,705 | 3,619 | 3,871 | 3,803 | 3,551 | |||||
Long Term Debt Current | - | - | - | - | 3,519 | 4,698 | 4,682 | 4,574 | 3,028 | 2,424 | 2,553 | 2,395 | |||||
Debt Current | 8,532 | 4,889 | 6,110 | 5,104 | - | 4,698 | - | - | - | - | - | - | |||||
Liabilities Current | 19,258 | 16,350 | 17,896 | 15,939 | 13,631 | 15,177 | 14,900 | 14,301 | 13,141 | 12,655 | 12,407 | 11,545 | |||||
Long Term Debt Noncurrent | 39,491 | 41,603 | 38,401 | 39,379 | 41,057 | 38,333 | 38,283 | 36,306 | 37,163 | 37,169 | 36,793 | 36,537 | |||||
Operating Lease Liability Noncurrent | 1,822 | 1,853 | 1,838 | 1,881 | 1,860 | 1,863 | 1,924 | 1,894 | 1,912 | 1,903 | 1,776 | 1,806 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Common Stock Value Outstanding | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -327 | -305 | -317 | -309 | -357 | -387 | -378 | -433 | -433 | -425 | -491 | -456 | |||||
Retained Earnings Accumulated Deficit | -5,978 | -5,724 | -5,020 | -4,087 | -3,164 | -2,115 | -1,807 | -1,170 | -1,185 | -1,352 | -1,989 | -1,850 | |||||
Stockholders Equity | -6,303 | -6,027 | -2,159 | -1,238 | -438 | 555 | -2,182 | -1,600 | -1,615 | 1,060 | 357 | 461 | |||||
Minority Interest | 3,325 | 3,256 | 3,176 | 3,156 | 3,081 | 3,054 | 2,968 | 2,939 | 2,885 | 2,834 | 2,834 | 2,764 | |||||
Liabilities And Stockholders Equity | 61,450 | 60,720 | 59,747 | 59,536 | 59,798 | 59,513 | 59,459 | 57,379 | 56,962 | 56,211 | 54,589 | 53,594 | |||||
Deferred Finance Costs Noncurrent Net | 433 | 436 | 416 | 429 | 432 | 369 | 378 | 371 | 381 | 333 | 341 | 349 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | |||||
Shares Outstanding | 223 | 225 | 230 | 236 | 243 | 250 | 255 | 259 | 263 | 266 | 269 | 273 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.36% | -13.54% | -14.46% | - | - | - | - | - | - | - | - | - |
| 2025 | 9.78% | 10.26% | 5.48% | 11.22% | 15.59% | 23.30% | 5.18% | 1.47% | 0.68% | 6.13% | -5.88% | -13.61% |
| 2024 | 3.19% | 9.95% | 4.52% | 8.38% | 12.99% | 16.03% | -9.42% | -15.19% | -13.28% | 4.41% | 5.12% | 10.29% |
| 2023 | - | - | - | 1.44% | -6.14% | -10.29% | 11.08% | 22.18% | 27.51% | 5.45% | 6.78% | -0.05% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.83 | 0.97 | 0.85 | 0.98 | 1.19 | 1.08 | 1.12 | 1.06 | 1.16 | 1.18 | 1.15 | 1.20 | |||||
| Quick Ratio | 0.75 | 0.86 | 0.76 | 0.86 | 1.06 | 0.97 | 1.00 | 0.94 | 1.02 | 1.02 | 0.99 | 1.03 | |||||
| Working Capital | -3.21B | -567.00M | -2.61B | -376.00M | 2.63B | 1.24B | 1.76B | 872.00M | 2.14B | 2.27B | 1.89B | 2.34B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -3.06 | -5.90 | -8.29 | -12.87 | -31.12 | 27.35 | -6.83 | -8.94 | -8.14 | 11.94 | 34.75 | 25.04 | |||||
| Interest Coverage TTM | 5.38 | 5.37 | 4.68 | 4.54 | 4.67 | 4.70 | 4.87 | 4.80 | 4.63 | 4.54 | 4.85 | 4.95 | |||||
| Debt Ratio | 0.31 | 0.27 | 0.30 | 0.27 | 0.23 | 0.26 | 0.25 | 0.25 | 0.23 | 0.23 | 0.23 | 0.22 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.26 | 1.26 | 1.25 | 1.24 | 1.23 | 1.22 | 1.22 | 1.23 | 1.22 | 1.20 | 1.19 | 1.18 | |||||
| Days Sales Outstanding TTM | 53.54 | 52.19 | 49.92 | 51.96 | 53.87 | 53.53 | 50.06 | 50.61 | 51.16 | 52.95 | 51.24 | 51.11 | |||||
| Receivables Turnover TTM | 6.82 | 6.99 | 7.31 | 7.02 | 6.78 | 6.82 | 7.29 | 7.21 | 7.14 | 6.89 | 7.12 | 7.14 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 35.42 | 32.49 | 25.90 | 23.75 | 23.17 | 22.00 | 22.84 | 21.76 | 20.41 | 18.96 | 20.04 | 20.04 | |||||
| Free Cash Flow Per Share TTM | 35.45 | 32.54 | 34.76 | 30.49 | 20.04 | 21.81 | 22.90 | 18.72 | 20.54 | 17.21 | 16.14 | 17.97 | |||||
| Dividend Per Share TTM | 3.05 | 2.87 | 2.93 | 2.86 | 2.77 | 2.67 | 2.67 | 2.60 | 2.54 | 2.43 | 2.42 | 2.39 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 97.01% | 97.03% | 97.04% | 97.03% | 97.07% | 97.08% | 97.09% | 97.09% | 97.05% | 97.02% | 96.99% | 96.99% | |||||
| Operating Profit Margin TTM | 12.82% | 13.01% | 12.50% | 12.08% | 12.02% | 12.07% | 12.55% | 12.38% | 12.04% | 11.86% | 13.72% | 14.11% | |||||
| Net Profit Margin TTM | 10.51% | 10.29% | 8.23% | 7.90% | 8.07% | 8.16% | 8.53% | 8.41% | 8.20% | 8.07% | 8.74% | 9.00% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 6.71% | 7.08% | 6.82% | 6.37% | 7.30% | 8.67% | 10.23% | 10.38% | 9.59% | 7.86% | 5.62% | 3.02% | |||||
| Net Income Growth (1Y) | 38.93% | 35.10% | 3.07% | 0.00% | 5.65% | 9.88% | 7.56% | 3.07% | -1.28% | -7.11% | -10.11% | -25.46% | |||||
| EPS Growth (1Y) | 53.44% | 47.79% | 13.63% | 9.19% | 13.14% | 15.75% | 13.59% | 8.33% | 3.38% | -0.99% | -5.21% | -20.56% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 13.15 | 14.13 | 16.14 | 15.84 | 14.64 | 13.33 | 17.35 | 14.39 | 15.86 | 13.80 | 11.83 | 14.60 | |||||
| P/B TTM | -16.75 | -39.69 | -45.75 | -73.51 | -193.13 | 138.33 | -47.20 | -51.67 | -53.71 | 68.27 | 182.96 | 176.54 | |||||
| P/S TTM | 1.38 | 1.45 | 1.33 | 1.25 | 1.18 | 1.09 | 1.48 | 1.21 | 1.30 | 1.11 | 1.03 | 1.31 | |||||
| Market Cap | 105.60B | 109.99B | 98.77B | 91.01B | 84.59B | 76.77B | 103.00B | 82.68B | 86.74B | 72.37B | 65.32B | 81.38B | |||||
| Enterprise Value | 152.68B | 155.44B | 142.28B | 134.55B | 128.11B | 117.87B | 143.08B | 122.72B | 125.64B | 111.02B | 103.77B | 119.45B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 7.93B | 7.69B | 8.10B | 7.29B | 4.95B | 5.64B | 5.88B | 4.89B | 5.43B | 4.69B | 4.38B | 4.93B | |||||
| Net Debt | 47.08B | 45.45B | 43.51B | 43.54B | 43.52B | 41.10B | 40.08B | 40.05B | 38.91B | 38.66B | 38.46B | 38.07B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
HCA Healthcare, Inc. (HCA) — SEC Financial Statements & Analysis
HCA Healthcare, Inc. (HCA) is a services-general medical & surgical hospitals, nec company. HCA Healthcare, Inc. trades on NYSE as: HCA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), HCA Healthcare, Inc. reported a 6.71% year-over-year revenue growth, a Gross Profit Margin of 97.01% (TTM), a Debt-to-Equity ratio of -3.06x, a Price-to-Sales (P/S) ratio of 1.38x (TTM), a Price-to-Book (P/B) ratio of -16.75x (TTM), at a market cap of $105.60B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 6.71%
- Gross Profit Margin TTM
- 97.01%
- Debt To Equity
- -3.06x
- P/S TTM
- 1.38x
- P/B TTM
- -16.75x
- Market Cap
- $105.60B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HCA Healthcare, Inc. in?
HCA Healthcare, Inc. (HCA) operates in the Services-General Medical & Surgical Hospitals, NEC industry.
What is HCA's market cap?
HCA Healthcare, Inc. (HCA) has a market capitalization of $105.60B as of 2026-03-31.
What is HCA's P/E ratio?
HCA Healthcare, Inc. (HCA)'s trailing twelve month P/E ratio is 13.15x as of 2026-03-31.
What exchange does HCA trade on?
HCA Healthcare, Inc. (HCA) trades on the NYSE.